Stay updated with breaking news from Dimensions Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wealth Dimensions Group Ltd. increased its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 13.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,752 shares of the medical research company’s stock after purchasing an additional 459 […]
Wealth Dimensions Group Ltd. trimmed its holdings in Vanguard Mid-Cap ETF (NYSEARCA:VO – Free Report) by 0.6% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 7,982 shares of the company’s stock after selling 52 shares during the quarter. Vanguard Mid-Cap ETF comprises approximately 0.7% of Wealth […]
Wealth Dimensions Group Ltd. decreased its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 4.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,109 shares of the company’s stock after selling 197 shares during the period. […]
Wealth Dimensions Group Ltd. increased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 6.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,801 shares of the biopharmaceutical company’s stock after buying an additional 1,069 shares during the quarter. Wealth Dimensions […]
Wealth Dimensions Group Ltd. trimmed its stake in shares of Cincinnati Financial Co. (NASDAQ:CINF – Free Report) by 33.1% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 9,757 shares of the insurance provider’s stock after selling 4,833 shares during the quarter. Wealth Dimensions Group […]